Analyst Ranking
Bottom 5%
#4635 out of 4868 analysts
Average Return
-3.61%
Win Rate
43%72 out of 169
Risk vs Reward
Poor
Good

Reni Benjamin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ambrx Biopharma IncAMAM
+188.96%$9.69$28.00
2023-11-19 -
2024-03-06
Buy
Ambrx Biopharma IncAMAM
+160.71%$10.74$28.00
2023-09-24 -
2024-03-06
Buy
Spark Therapeutics IncONCE
+145.65%$45.41$111.55
2018-11-06 -
2019-11-07
Strong Buy
Ambrx Biopharma IncAMAM
+138.91%$11.72$28.00
2023-11-28 -
2024-03-06
Buy
Blueprint Medicines CorpBPMC
+114.18%$44.29$94.86
2023-03-29 -
2024-03-28
Buy

Reni Benjamin Analyst Color

Get additional color on Reni Benjamin's coverage of popular stocks

Reni Benjamin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Prelude Therapeutics IncPRLD
5Buy$4.00+316.67%Reiterates
2 days ago
Kura Oncology IncKURA
10Buy$28.00+326.83%Reiterates
2 days ago
Summit Therapeutics IncSMMT
3Buy$40.00+65.84%Reiterates
3 days ago
Cue Biopharma IncCUE
4Buy$2.00+164.90%Reiterates
a month ago
Bioatla IncBCAB
9Buy$1.00+105.76%Maintains
a month ago
Sana Biotechnology IncSANA
4Buy$5.00+163.16%Upgrades
a month ago
Allogene Therapeutics IncALLO
6Buy$5.00+197.62%Upgrades
2 months ago
Suro Capital CorpSSSS
1Buy$8.00+73.16%Maintains
2 months ago
Skyward Specialty Insurance Group IncSKWD
1Buy$60.00+13.02%Reiterates
2 months ago
Blueprint Medicines CorpBPMC
20Buy$125.00+39.66%Reiterates
2 months ago
Bicycle Therapeutics PLCBCYC
13Buy$26.00+203.74%Reiterates
2 months ago
Workday IncWDAY
1Buy$315.00+28.57%Reiterates
3 months ago
Steris PLCSTE
1Buy$265.00+17.91%Reiterates
3 months ago
Werewolf Therapeutics IncHOWL
5Buy$4.00+343.46%Maintains
4 months ago
Sutro Biopharma IncSTRO
8Buy$17.00+1,519.05%Reiterates
5 months ago
Lava Therapeutics NvLVTX
6Hold$6.00+380.00%Downgrades
5 months ago
Beigene LtdONC
1Buy$288.00+10.85%Initiates Coverage On
7 months ago
Iovance Biotherapeutics IncIOVA
9Buy$23.00+540.67%Maintains
10 months ago
Incyte CorpINCY
13Buy$93.00N/AReiterates
a year ago
Ambrx Biopharma IncAMAM
3Buy$15.00N/AReiterates
a year ago
Inhibrx IncINBX1
5Buy$27.00N/AReiterates
a year ago
Deciphera Pharmaceuticals IncDCPH
5Buy$23.00N/AReiterates
2 years ago
Adicet Bio IncACET
2Buy$19.00N/AReiterates
2 years ago
Cti Biopharma CorpCTIC
4Buy$9.00N/AReiterates
2 years ago
Seagen IncSGEN
5Buy$168.00N/AMaintains
2 years ago
Spectrum Pharmaceuticals IncSPPI
3Buy$4.00N/AReiterates
2 years ago
Effector Therapeutics IncEFTR
5Buy$25.00N/AMaintains
2 years ago
Compugen LtdCGEN
1Buy$4.00N/AMaintains
3 years ago
Trillium Therapeutics IncTRIL
1HoldN/AN/ADowngrades
4 years ago
Aceragen IncACGN
1HoldN/AN/ADowngrades
4 years ago
Constellation Pharmaceuticals IncCNST
1Hold$36.00N/AInitiates Coverage On
5 years ago
Eterna Therapeutics IncERNA
2Buy$5.00N/AMaintains
6 years ago
Macrogenics IncMGNX
2HoldN/AN/AUpgrades
6 years ago
Regenxbio IncRGNX
2Strong BuyN/AN/AUpgrades
6 years ago
Leap Therapeutics IncLPTX
2Buy$80.00N/AMaintains
6 years ago
Voyager Therapeutics IncVYGR
2Strong BuyN/AN/AUpgrades
6 years ago
Spark Therapeutics IncONCE
1Strong Buy$72.00N/AUpgrades
6 years ago
Adverum Biotechnologies IncADVM
2HoldN/AN/ADowngrades
6 years ago
Adaptimmune Therapeutics PLCADAP
1Buy$16.00N/AMaintains
7 years ago
Adma Biologics IncADMA
2Buy$10.00N/AMaintains
7 years ago
Tg Therapeutics IncTGTX
1Buy$12.00N/ADowngrades
7 years ago
Urogen Pharma LtdURGN
1HoldN/AN/ADowngrades
7 years ago
Audentes Therapeutics IncBOLD1
1HoldN/AN/AInitiates Coverage On
8 years ago
Juno Therapeutics IncJUNO
2BuyN/AN/AUpgrades
8 years ago
Bellicum Pharmaceuticals IncBLCM
2Buy$180.00N/AMaintains
8 years ago
Vivosim Labs IncVIVS
1Buy$1,200.00N/AInitiates Coverage On
8 years ago
Invivo Therapeutics Holdings CorpNVIVQ
1Strong Buy$243,750.00N/AInitiates Coverage On
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.